Stocks in news: Axis Bank, Mankind Pharma, Bank of Baroda, Laurus Labs, Wipro

GIFT Nifty on the NSE IX traded 7 points, or 0.03 per cent, higher at 21,078.50, signaling that Dalal Street was headed for muted start on Wednesday.

Here's a slew of stocks that will be in focus today for various reasons.

Axis Bank
Private equity firm Bain Capital is likely to sell a minor stake worth Rs 3,700 crore in Axis Bank through a block deal on Wednesday, according to media reports.


Mankind Pharma
Mauritius-based Beige Ltd has sold partial stake in Mankind Pharma through bulk deals on Tuesday. The investors have sold about 1.44 crore shares or 3.6% stake at Rs 1,832 apiece, taking the deal value to Rs 2,640 crore.

Read more: Here's the trading setup for today's session

Bank of Baroda
A meeting of capital raising committee of the Bank is scheduled to be held on December 15 to discuss and finalize the quantum of the first tranche of Tier II/Sub debt instruments issue within the Board approved capital raising plan.

Shilpa Medicare
Shilpa Medicare's Bengaluru unit has received approval from TGA, Australia for manufacture, labeling, packaging and testing of medicinal Oral Mouth Dissolving Films (Wafers).

Equitas Small Finance Bank
The Board approved the appointment of Ashwini Biswal as Chief Compliance Officer of the Bank for a period of five years.

Laurus Labs
US FDA has issued a Form 483 with five observations after inspecting the subsidiary's manufacturing facility in Parawada.

Wipro
Wipro announced that it has entered into a new agreement with RSA, one of the world’s leading general insurance companies to help accelerate RSA’s migration to the cloud and build a compliant, secure, and scalable IT infrastructure.